A phase II study of the safety and efficacy of the multidrug resistance inhibitor VX-710 combined with doxorubicin and vincristine in patients with recurrent small cell lung cancer
about
A phase II study of the safety and efficacy of the multidrug resistance inhibitor VX-710 combined with doxorubicin and vincristine in patients with recurrent small cell lung cancer
description
im Januar 2007 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 01 March 2007
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована у 2007
@uk
name
A phase II study of the safety ...... current small cell lung cancer
@en
A phase II study of the safety ...... current small cell lung cancer
@nl
type
label
A phase II study of the safety ...... current small cell lung cancer
@en
A phase II study of the safety ...... current small cell lung cancer
@nl
prefLabel
A phase II study of the safety ...... current small cell lung cancer
@en
A phase II study of the safety ...... current small cell lung cancer
@nl
P2093
P356
P1433
P1476
A phase II study of the safety ...... current small cell lung cancer
@en
P2093
Bruce E Johnson
Corey J Langer
Helen J Ross
Marcus Neubauer
Matthew W Harding
Melvin Moore
Thomas J Lynch
P304
P356
10.1002/CNCR.22492
P407
P50
P577
2007-03-01T00:00:00Z